Health Condition 1: L501- Idiopathic urticaria
Conditions
Interventions
Intervention1: narrow band utraviolet B: Patients in will be advised to come for NBUVB phototherapy every alternate day for 8 weeks. The NBUVB will be given at starting dose of 200mJ/cm2 with percenta
Sponsors
none
Eligibility
Inclusion criteria
Inclusion criteria: 1. All diagnosed patients of CSU > 12 years 2. Patients of CSU who are not responding to the conventional dose of oral antihistamine 3. Patients who are willing to come for phototherapy
Exclusion criteria
Exclusion criteria: 1.Patients who have history of phtosentivity, photoallergy, family or self-history of any cutaneous tumor. 2. Patients who are not willing to come for phototherapy 3. Patient with history of food or drug allergy 4. Patients of physical urticaria 5. Patients with history of angioedema 6. Pregnant females
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in urticaria severity measured by UAS at the end of 8week of treatment in both the groups.Timepoint: Improvement in urticaria severity measured by UAS at the end of 8week of treatment in both the groups. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Assessment of DLQI and baseline, 8 weeks and after completion of 20 week of study period. 2. Comparison of frequency relapses in each group at 28 weeks of study. 3. Comparison of pill burden in both the group at 28 weeks of study.Timepoint: 8, 20 and 28 weeks | — |
Countries
India
Contacts
Public ContactShiwangi Rana
all india institute of medical sciences gorakhpur
Outcome results
None listed